Trial Profile
K-001 Treatment of Advanced Pancreatic Cancer: Phase I Clinical Trial of Monotherapy's Tolerability
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2021
Price :
$35
*
At a glance
- Drugs K 001 (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology
- 22 Nov 2017 New trial record